1887

Small mustelids (British species excluding ferrets)*

Note: * Drug doses for small mustelid species as a general rule can be extrapolated from ferret doses. Reader is referred to .

Drug Dose Comments
  • Gaseous anaesthesia can be used in small mustelids
Ketamine
  • 5–10 mg/kg i.m.
  • 20–30 mg/kg i.m.
  • For mink
  • For stoats and weasels
Ketamine + diazepam
  • Ketamine (25 mg/kg) + diazepam (25 mg/kg) i.m.
  • For stoats and weasels
Ketamine + medetomidine
  • Ketamine (10 mg/kg) + medetomidine (0.2 mg/kg) i.m.
  • Ketamine (5 mg/kg) + medetomidine (0.1 mg/kg) i.m.
  • Ketamine (10 mg/kg) + medetomidine (0.2 mg/kg) i.m.
  • For polecats
  • For stoats
  • For pine martens
Atipamezole
  • 1 mg/kg i.m. (i.e. 5x dose (mg/kg) medetomidine used)
  • 0.5 mg/kg (half i.v.; half i.m.) (i.e. 5x dose (mg/kg) medetomidine used)
  • Reversal of medetomidine: 5x the medetomidine dose (i.e. equal volume of the 5 mg/ml atipamezole solution)
  • In common with most species, a delay in reversal of medetomidine of at least 20 minutes after the administration of combinations with ketamine is recommended
  • For the reversal of medetomidine given at 0.2 mg/kg (e.g. for polecats and pine martens)
  • For the reversal of medetomidine given at 0.1 mg/kg (e.g. for stoats)
Buprenorphine
  • 0.01–0.05 mg/kg i.v., i.m., s.c. q8–12h
  • Opioid analgesic for mild/moderate pain
  • Can be used in addition to NSAIDs
Carprofen
  • 1 mg/kg p.o. q12–24 h
  • The usual considerations for the careful use of NSAIDs in dehydrated, hypovolaemic or hypertensive animals, as well as those with underlying gastrointestinal disease, should be observed
  • Use with a histamine (H2) receptor antagonist
Ketoprofen
  • 0.5–1 mg/kg i.m., s.c., p.o. q24h
Meloxicam
  • 0.2 mg/kg i.m., s.c., p.o. q24h
  • Antibiotic use (both appropriate and inappropriate) imposes a powerful selection pressure on bacteria and is the primary driver of antibiotic resistance. Eliminating unnecessary use in people and animals is, therefore, essential to safeguard this invaluable resource. Prudent use is especially indicated where treated wild animals are being returned to the wild. The reader is referred to the Guidelines for responsible antibiotic use for further information (https://www.bsavalibrary.com/content/formulary/backmatter/exotic-petsguidelinesforresponsibleantibacterialuse)
Amoxicillin/clavulanate (co-amoxiclav)
  • 12.5–25 mg/kg p.o. q8–12h
  • General broad-spectrum antibacterial use
Enrofloxacin
  • 10–20 mg/kg i.m., s.c., p.o. q12–24h
  • Fluroquinolones should ideally be reserved for infections where culture and sensitivity testing predict a clinical response and use of first- and second- line antimicrobials would not be considered effective
  • Injectable form can cause inflammation and necrosis
  • Parasiticide use in wildlife may reduce the development of natural resistance to parasites, as well as exerting selection pressure on organisms which can lead to drug resistance and may risk environmental contamination. Careful selection and use of these drugs, only where there is a clinical need, and then using narrow spectrum products, is essential where treated wild animals are being returned to the wild. Reader is referred to the joint BVA, BSAVA and BVZS policy statement
Fenbendazole
  • 20 mg/kg p.o. q24h for 3 days
  • For the treatment of nematode infestation
Ivermectin
  • 0.2–0.4 mg/kg s.c., p.o.; repeat after 14 days
  • For the treatment of nematode and mite infestations
Ranitidine
  • 3.5 mg/kg p.o. q12h
  • Histamine (H2) receptor antagonist
  • For the prevention/treatment of gastric ulceration
Sucralfate
  • 25–125 mg/kg p.o. q8–12h
  • For the treatment of gastric ulcers
  • Give before meals (requires acidic pH)
NSAID(s) = non-steroidal anti-inflammatory drug(s)

Fowler ME (1995) , 2nd edition. Iowa State University Press, Ames, Iowa

Hall LW, Clarke KW and Trim CM (2001) . WB Saunders, London

Johnson-Delaney CA (2009) Ferrets: anaesthesia and analgesia. , ed. E Keeble and A Meredith, pp. 245–253.

Fournier-Chambrillon C, Chusseau JP, Dupuch J et al. (2003) Immobilization of free-ranging European mink () and polecat () with medetomidine-ketamine and reversal by atipamezole. 29, 393–399

Kreeger TJ (1997) . Wildlife Pharmaceuticals, Inc. Fort Collins, Colorado

Arnemo JM, Moe RO and Søli NE (1994) Immobilization of captive pine martens () with medetomidine-ketamine and reversal with atipamezole. 25, 548–554

Carpenter JW and Harms CA (2022) , 6th edition. Elsevier, Oxford

Morrisey J (2009) Ferrets: therapeutics. , ed. E Keeble and A Meredith, pp. 237–244.

Bourne D (2016) Other mustelids. , 2nd edition, ed. E Mullineaux and E Keeble, pp. 242–252. BSAVA Publications, Gloucester

https://www.bva.co.uk/take-action/our-policies/responsible-use-of-parasiticides-for-cats-and-dogs/

BSAVA Library https://www.bsavalibrary.com/

BVA, BSAVA, BVZS joint position statement: Responsible use of parasiticides https://www.bva.co.uk/take-action/our-policies/responsible-use-of-parasiticides-for-cats-and-dogs/

Vincent Wildlife Trust https://www.vwt.org.uk

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error